MAnTRA: Mri-linAc Treatments for Radiotherapy Patients. A Pilot study on the use of the Australian MRI –Linac to Treat Cancer Radiotherapy Patients.

South Western Sydney Local Health District0 个研究点目标入组 10 人开始时间: 2021年4月15日最近更新: 2022年11月7日

适应症

试验速览

暂无简介。

•18 years or older
•- Have the ability to give informed consent with the clear understanding that this is a prototype cancer radiation therapy system and not a commercially available and supported system
•- A diagnosis of cancer with a palliative indication for radiotherapy and referral to the Liverpool or Macarthur Cancer Therapy Centres
•- A treatment site and prognosis that, in the opinion of the treating physician, is clinically appropriate for this MRI-Linac feasibility trial using conformal radiotherapy in consultation with medical physicists and radiation therapists. The treatment fields used for planning must be able to be accommodated for the particular patient on the MRI-Linac. Examples may include (but are not restricted to) patients presenting with:
•- Cervical-spine metastasis
•- Whole brain
•- Recurrent brain metastasis
•- Bone metastasis
•- Soft tissue metastasis
•- ECOG status 0-2

•- Pain in the treatment position.
•- Resources not available to reasonably expect to commence treatment within two weeks of consent
•- Patient unable to physically fit into the MRI-Linac patient treatment space
•- Contraindication to MRI as according to departmental protocol.
•- Contraindication to standard radiation therapy
•- Pregnant women

发起方